Trademark: DALVANCE
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for DALVANCE
We do not have any records of a proof of use for DALVANCE at this moment.
Possible trademark infringements of DALVANCE
Basic Information about DALVANCE
- Serial Number
- 85741315
- Filing Date
- 28 Sep 2012
- Registration Number
- 4656717
- Registration Date
- 16 Dec 2014
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of DALVANCE on the blockchain with WikiTrademarks.io.
- First use of DALVANCE anywhere
- DALVANCE was first used on 07 Jul 2014 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 006; 018; 044; 046; 051; 052
Who owns DALVANCE?
1. ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED DUBLIN 17
2. Durata Therapeutics Holding C.V. Grand Cayman
3. Durata Therapeutics Holding C.V. Grand Cayman
4. Durata Therapeutics Holding C.V. Grand Cayman KY1-1102
Correspondent
- Matthew O. Brady
- Allergan, Inc.
- 2525 Dupont Drive
- Irvine, CA 92612
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io